Browsing Category
Stabilizer
Molecular Interactions for the Curcumin-Polymer Complex with Enhanced Anti-Inflammatory Effects
The molecular interactions between compound and polymeric carriers are expected to highly contribute to high drug load and good physical stability of solid dispersions.
In this study, a series of amorphous solid dispersions (ASD) of Curcumin (Cur) were prepared with different polymers by the…
Read More...
Read More...
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3…
Background
Renal cell carcinomas (RCC) harboring a TFE3 gene fusion (TfRCC) represent an aggressive subset of kidney tumors. Key signaling pathways of TfRCC are unknown and preclinical in vivo data are lacking. We investigated Akt/mTOR pathway activation and the preclinical efficacy of dual…
Read More...
Read More...
Microencapsulation Curcuminoids for Effective Delivery in Pharmaceutical Application
Curcuminoids have been long proven to possess antioxidant, anti-inflammatory and antibacterial properties which are crucial in their role as a pharmacological active agent.
However, its poor solubility, high oxidative degradation, light sensitivity and poor bioavailability have been huge hurdles…
Read More...
Read More...
Kollidon® 30 – The original from BASF
Kollidon® 30 is the solution for endless opportunities in pharmaceutical formulations – use it as a binder, pore former, stabilizer, thickener, solubilizing agent, crystallization inhibitor and countless more.
Click on the poster to see it in bigger size.
PDF DOWNLOAD: KOLLIDON® 30
More…
Read More...
Read More...
A brief review on Kollidon
Polyvinylpyrrolidone includes soluble and insoluble grades; soluble grades are synthesised by the mechanism of polymerization, the free radical polymerization into water by using hydrogen peroxide as an initiator, the mechanism which terminates the polymerisation reaction makes it probable to…
Read More...
Read More...
Determining the minimum amount of Kollidon® SR required in a tableting blend to obtain a matrix…
Kollidon® SR-based matrix formulations are well known for obtaining strong sustained release functionality. Depending on the solubility of the active ingredient and the required dissolution profile, pore formers need to be added for adjusting drug release.
This work was to investigate the maximum…
Read More...
Read More...
Delivery of Poorly Soluble Drugs via Mesoporous Silica: Impact of Drug Overloading on Release and…
The most important properties of promising drug candidates for oral dosage form are aqueous solubility and intestinal permeability. Over 40% of drugs on the market are BCS class II and IV, which have low solubility. Furthermore, new chemical entities are even less soluble compared to marketed…
Read More...
Read More...
Stabilizing excipients for engineered clopidogrel
Clopidogrel bisulfate (CB) is a golden antiplatelet treatment, yet its benefits are limited by its low bioavailability (<50%) caused by poor intestinal solubility and absorption.
The present study aims to improve CB intestinal solubility and absorption through developing a novel stable dry CB…
Read More...
Read More...
Calcium alginate beads
Calcium alginate beads loaded with Mg(OH)2 improve L. casei viability under simulated gastric condition
Alginate beads are commonly used for protection of probiotics against adverse environmental conditions. However, alginate beads are unable to provide complete cell viability under stringent…
Read More...
Read More...
Drug delivery innovation: Vitamin E TPGS and Polyamino acids
Vitamin E TPGS, a water soluble derivative of natural Vitamin E, is a multirole excipient for pharmaceutical drug delivery innovation. Vitamin E TPGS is a non-ionic surfactant used as:
solubilizer of poorly soluble drugs
absorption enhancer
emulsifier
vehicle for lipid-based drug…
Read More...
Read More...